Laura Pina Vegas

Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a nationwide cohort study

Léa Hoisnard, Laura Pina Vegas, Rosemary Dray‐Spira et al. · Annals of the Rheumatic Diseases · 2022 · 118 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Association Between Biologics Use and Risk of Serious Infection in Patients With Psoriasis

Laëtitia Penso, Rosemary Dray‐Spira, Alain Weill et al. · JAMA Dermatology · 2021 · 97 citations · Full text

Medicine, Dermatology, Pharmacotherapy +11

Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database

Laura Pina Vegas, Laëtitia Penso, Pascal Claudepierre et al. · JAMA Dermatology · 2022 · 61 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study

Laura Pina Vegas, Philippe Le Corvoisier, Laëtitia Penso et al. · Lara D. Veeken · 2021 · 60 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Epidemiologic study of patients with psoriatic arthritis in a real-world analysis: a cohort study of the French health insurance database

Laura Pina Vegas, É. Sbidian, Laëtitia Penso et al. · Lara D. Veeken · 2020 · 47 citations

Medicine, Clinical Sciences, Internal Medicine +15